Summary:
Semler Scientific raised $21.5 million through an ATM offering.
Acquired 215 BTC for $17.7 million at an average price of $82,502.
Now holds a total of 1,273 BTC, with an average purchase price of $69,682.
BTC Yield reached 37.3% since adopting its bitcoin treasury strategy.
BTC Yield is a key performance indicator to assess the accretion of bitcoin for shareholders.
Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in healthcare technology, has made significant strides in the cryptocurrency space, announcing updates on its Bitcoin activities and holdings.
BTC Update
During the period from November 6 to November 15, 2024, Semler acquired 215 bitcoins for $17.7 million, averaging $82,502 per bitcoin, including fees. As of November 15, 2024, the company holds a total of 1,273 bitcoins, purchased at an average price of $69,682 per bitcoin, aggregating to $88.7 million.
ATM Update
In its Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., Semler has raised $21.5 million by selling 505,544 shares since the effective date of its registration statement on August 13, 2024.
BTC Yield as a Key Performance Indicator (KPI)
From October 1 to November 15, 2024, Semler's BTC Yield stood at 18.9%, while from July 1 to November 15, 2024, it reached 37.3%. This metric is crucial for assessing the effectiveness of Semler's strategy in acquiring Bitcoin to enhance shareholder value.
Eric Semler, the chairman, stated, "We have achieved a BTC Yield of 37.3% since adopting our bitcoin treasury strategy in the second quarter of this year, demonstrating substantial bitcoin accretion for our stakeholders."
Understanding BTC Yield KPI
BTC Yield represents the percentage change of the ratio between Semler's bitcoin holdings and its Assumed Diluted Shares Outstanding. It is utilized to evaluate the performance of bitcoin acquisitions. However, it is important to note that BTC Yield should not be interpreted as a traditional yield or a measure of return on investment.
Semler emphasizes that while BTC Yield is a useful KPI, it does not reflect the overall trading price of its shares, which can be influenced by a variety of factors. Investors are encouraged to consider Semler's financial statements and SEC filings for a comprehensive understanding of its financial health and strategic decisions.
About Semler Scientific
Semler Scientific is dedicated to developing technology products for healthcare providers to address chronic diseases. Its flagship product, QuantaFlo®, aids in diagnosing cardiovascular diseases and is FDA-cleared. The company is actively investing in Bitcoin as its primary treasury asset.
:max_bytes(150000):strip_icc()/BTCUSDChart-183b2dc172664a9290ef2a50c1429900.gif)
Comments